Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms- |
Target |
Action degraders |
Mechanism IRAK1 degraders(Interleukin-1 receptor-associated kinase 1 degraders) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Arthritis | Discovery | - | 29 Nov 2024 | |
Cardiovascular Diseases | Discovery | - | 29 Nov 2024 | |
Immune System Diseases | Discovery | - | 29 Nov 2024 | |
Inflammation | Discovery | - | 29 Nov 2024 | |
Liver Diseases | Discovery | - | 29 Nov 2024 | |
Metabolic Diseases | Discovery | - | 29 Nov 2024 | |
Neoplasms | Discovery | - | 29 Nov 2024 | |
Neurodegenerative Diseases | Discovery | - | 29 Nov 2024 | |
Respiratory Diseases | Discovery | - | 29 Nov 2024 | |
Urogenital Diseases | Discovery | - | 29 Nov 2024 |